BML Capital Management, LLC

ZIONSVILLE, IN · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 6, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$186.4M2026 Q3+ $1.2M options (notional, not included)
Positions20
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.89.0%

BML Capital Management, LLC reported 20 positions worth $186.4M as of September 30, 2026 (13F filed November 6, 2026). Largest holding: ACRS (30.7%). Biggest move: reduce ACRS ($5.4M).

10 / 20 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 ACRSAclaris Therapeutics$57.6M30.71%10,955,000——-28.9%
▸ 2 AVIRAtea Pharmaceuticals$35.2M18.75%6,753,658———
▸ 3 ENGNenGene Therapeutics$13.3M7.11%6,669,908——+20.5%
▸ 4 PMVPPMV Pharmaceuticals$12.2M6.52%7,330,000———
▸ 5 KHCKraft Heinz$10.8M5.75%475,000——+10.3%
▸ 6 TLYSTilly'S$10.0M5.31%2,150,000——-8.9%
▸ 7 KMXCarmax$9.5M5.07%172,500——-6.3%
▸ 8 OMOutset Medical$7.6M4.03%2,519,701——+24.3%
▸ 9 TGTTarget$5.9M3.13%37,500——+2.3%
▸ 10 SEERSeer$4.9M2.60%2,186,587——-33.6%

Pro Feature

The remaining 10 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does BML Capital Management, LLC hold as of Q3 2026?

BML Capital Management, LLC reported 20 positions worth $186.4M in its Q3 2026 13F filing. Largest positions: ACRS (30.7%), AVIR (18.8%), ENGN (7.1%), PMVP (6.5%) and KHC (5.8%).

What did BML Capital Management, LLC buy in Q3 2026?

New positions: SEER, LENZ and KPTI. Added to: CNTB, PMVP, KHC and ORAMED PHARMACEUTICALS INC.

What did BML Capital Management, LLC sell in Q3 2026?

Reduced: ACRS, TSLA, AVIR and JANX. Sold out entirely: CORZ.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.